News Category
AOM Capital's $3.8 million bridge loan to a healthcare provider underscores growing demand for specialty financing solutions to manage cash flow gaps ...
Nanox's new distribution agreement with Associated X-Ray Imaging Corp. aims to increase access to its innovative 3D tomosynthesis system in New Englan...
Silver and gold ETFs faced significant selling pressure after markets reacted to a shift in U.S. monetary policy expectations from Warsh's Jackson Hol...
A large study reveals that the timing of brain metastasis development significantly impacts survival in colorectal cancer patients, underscoring the n...
A new report reveals that investors have lost at least $4.7 billion in cryptocurrency ventures associated with President Donald Trump, underscoring th...
SS Innovations International's SSi Mantra system is scaling internationally with a 39.4% revenue increase and 30 new installations in Q2, positioning ...
Onco-Innovations has reported key preclinical progress for its PNKP inhibitor ONC010, including high-purity API manufacturing and plans for a First-in...
VERAXA Biotech strengthens its leadership with the appointment of Raju Willener as CFO, bringing extensive financial expertise to support its BiTAC pl...
AgeReverse's participation in the ECRM Vitamin, Weight Management & Sports Nutrition Session marks a strategic step in its U.S. expansion, introducing...
Adrian Pelkus's memoir 'Adrian, An American Artificer' highlights his inventions and the ongoing struggle for inventors' rights in the U.S. patent sys...
ZC Institute's announcement of Kardashev One, a fusion reactor concept using spacetime-distortion technology to recover lost neutrons, marks a pivotal...
BioVersys will showcase its anti-MDR bacteria pipeline at the H.C. Wainwright conference, highlighting progress in addressing antimicrobial resistance...
OS Therapies is set to present at the Moody Capital conference amid critical regulatory milestones for its lead candidate OST-HER2, potentially reshap...
A Swiss-led preclinical study reveals that administering immunotherapy before surgery significantly improves glioblastoma treatment outcomes, potentia...
Frontieras North America leverages its management team's extensive experience in engineering, energy, and finance to navigate the challenging path fro...
Nightfood Holdings, through TechForce Robotics, is broadening its AI-driven enterprise automation platform into pharmaceuticals, semiconductors, and i...
Greenland Mines highlights the closing of its Sarfartoq rare earths acquisition and progress at Skaergaard, underscoring its strategic position in cri...
Clym Environmental's new facility uses innovative ozone technology and solar power to process biohazardous waste, marking a significant advancement in...
The FDA's failure to aggressively enforce against online sellers of the unapproved investigational drug retatrutide has enabled a dangerous black mark...
Viromed Medical AG has strengthened its Medical Advisory Board with Prof. Dr. Michael A. Rubhausen, whose expertise in spectroscopy and materials rese...
Regentis Biomaterials is progressing its regenerative cartilage repair implant GelrinC through clinical trials and manufacturing improvements, potenti...
SuzieQ Holdings Inc. will be featured at the Moody Capital Solutions 2026 conference, highlighting its role in building the measurement and sovereignt...
20 Slash 20 Inc.'s participation in the Moody Capital Solutions 2026 Disruptive Growth and Life Sciences Conference highlights the commercial potentia...
New research from Mass General Brigham links unintended thymus radiation during lung cancer treatment to worse outcomes, suggesting that protecting th...
Tonix Pharmaceuticals' participation in the Cantor 2026 Global Healthcare Conference underscores its commercial-stage evolution and the strategic impo...
Earth Science Tech shareholders approved key governance changes, including a reverse stock split contingency and retirement of Series B Preferred Stoc...
American Fusion Inc. has uplisted to the OTCQB Venture Market and expanded its patent portfolio, signaling progress in its fusion energy development a...
Hartig Drug Company now offers Nefense nasal care products at select locations, providing drug-free nasal hygiene options supported by clinical resear...
Judith A. Swack, Ph.D., offers insights into why trauma keeps people stuck despite self-care, and introduces her HBLU™ methodology to clear trauma at ...
NurExone Biologic's upcoming presentation at a major life sciences conference highlights its exosome-based therapeutic platform and U.S. expansion str...
A Seeking Alpha analysis highlights SS Innovations International as a potentially stronger long-term investment than Intuitive Surgical due to its rap...
Olenox Industries moves its North Texas multi-well program into field execution, with seismic work starting in September 2026, potentially supporting ...
Datavault AI's participation in a major investment conference underscores its strategic focus on AI-driven data valuation and monetization, potentiall...
Gold's rapid ascent past $4,750 triggers a technical warning about stretched momentum, highlighting the delicate balance for investors and stakeholder...
The article examines the growing trend of U.S. companies dropping GLP-1 coverage from employee health plans due to escalating costs, highlighting the ...
CNS Pharmaceuticals' Chief Business Officer details the company's strategic approach to in-licensing and acquisitions in oncology and neurology, highl...
Silynx's integration of drone detection and life-sign monitoring into its in-ear communication systems underscores its commitment to frontline safety ...
The launch of the third InnoHK research cluster at Hong Kong Science Park positions Hong Kong as a global hub for sustainable development, energy, adv...
Dr. Salman Fazal, a hematologist and stem cell transplant expert at UPMC Hillman Cancer Center, has been recognized as a Castle Connolly Top Doctor fo...
New federal policies aiming to attract AI talent conflict with visa restrictions and AI-driven vetting, prompting experts to recommend self-petition r...
Quantum BioPharma receives a 'Buy' rating and $8.00 price target from Rodman & Renshaw, highlighting the potential of its lead candidate Lucid-MS for ...
NanoViricides is progressing its measles treatment NV-387 toward a Phase II trial as measles cases rise, leveraging strong preclinical data and FDA de...
TransCode Therapeutics' lead candidate TTX-MC138 demonstrated significant survival benefits in a preclinical breast cancer bone metastasis model, supp...
Wrap Technologies is addressing the emerging challenge of detecting drones that do not rely on radio-frequency signals, using a passive, physics-based...
Oragenics provides updates on its Phase IIa trial for ONP-002, FDA interactions, and NYSE American listing compliance, highlighting progress and chall...
Earth Science Tech's acquisition of Zoolzy LLC enhances its profit margins, expands ingredient access, and enters the veterinary market, strengthening...
Italian pharmaceutical company DuLac Farmaceutici accelerates its U.S. expansion through new e-commerce channel OneLavi and planned participation in E...
Neurologist Dr. Eric Anderson explains central sensitization as a key factor in chronic pain, highlighting a brain-first treatment approach that could...
